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Background
There are few prospective data on bone mass and qual-
ity in a large number of patients with Juvenile Systemic
Lupus Erythematosus (JSLE). However, there are very
few data comparing evaluating the bone mass and qual-
ity determinants using dual energy X-ray absorptiometry
(DXA), peripheral quantitative computed tomography
(pQCT), and quantitative ultrasound (QUS) in JSLE.
Aim
To assess the prevalence and to identify the main pre-
dictors of reduced BMD and bone quality in a cross-sec-
tional evaluation of a large cohort of SLE patients with
disease onset before 18 years.
Methods
Seventy nine patients with juvenile onset SLE (64
females, 15 males, median age 21.0 years, range 14.5 to
39.0 years) treated at the Transition Clinic of Rheuma-
tology Section from January 2008 to December 2010
were evaluated. In all subjects DXA at the lumbar spine,
pQCT at radius and phalangeal osteosonography were
performed at the same time. The data obtained were
compared with 80 age- and sex- matched healthy sub-
jects. All patients at evaluation were receiving Hydroxy-
chloroquine, 50/79 low dose steroids, 35 mycophenolate
mofetil, 10 azathioprine and 2/69 had received four
infusions of Rituximab.
Results
At DXA examination, all JSLE patients showed a
reduced BMD SDS (p <0.001), total trabecular density,
strain strength index, muscle area, cortical bone area, fat
area (p <0.001) in comparison to controls. However, we
did not find any significant statistical differences regard-
ing AD-SoS and QUS. A significant correlation was
found between BMD SDS, disease activity (SLEDAI
score), dose and duration of corticosteroids therapy (p
<0.001).
Conclusions
JSLE patients have a low bone mass and impaired bone
structure in comparison to controls. A close monitoring
of bone mass, a better control of disease activity, physi-
cal activity, and a dietary intake of calcium and vitamin
D are advocated to ameliorate the bone mass.
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